Study of serum magnesium levels in pre-diabetics and its correlation to body mass index


  • Ajeesh Koshy Department of Medicine, Pushpagiri Medical College, Thiruvalla, Kerala, India
  • Roshan M. Department of Medicine, Father Muller Medical College, Mangalore, Karnataka, India



BMI, Hypomagnesemia, Pre-diabetes, Serum magnesium


Background: Diabetes is a growing public health burden across the world, particularly in the developing countries. Homeostasis of the trace elements such as magnesium has been found to play an important role in the pathogenesis of diabetes and diabetic complications. Studies had found out an association between serum magnesium and incident diabetes; where diabetes may induce urinary magnesium loss. But in pre-diabetes, serum glucose levels are below the threshold for urinary magnesium wasting and hence unlikely to influence serum magnesium levels. This study was done to assess their serum magnesium levels and find its correlation.

Methods: This cross sectional study was done among 120 pre-diabetic subjects. Pre-diabetes was diagnosed as per ADA guidelines and body mass index was calculated according to Asian guidelines of BMI. Serum magnesium levels were done for all of them and statistically analysed to correlate the serum magnesium with body mass.

Results: The present study observed that 69 out of 120 pre-diabetics, 57.5% have low magnesium levels. This study showed that 57.5% of pre-diabetics is having normal body mass index, out of which more than half of them are having normal serum magnesium. But out of 12 obese pre-diabetics, 11 were having low serum magnesium 91.6%. (P value 0.026 which is statistically significant).

Conclusions: This study observed that serum magnesium levels are low in Pre-diabetics. Significant hyomagnesemia has been seen in pre-diabetics with high BMI compared to those with normal BMI.



Kieboom BC, Ligthart S, Dehghan A, Kurstjens S, de Baaij JH, Franco OH, et al. Serum magnesium and the risk of prediabetes: a population-based cohort study. Diabetologia. 2017;60(5):843-53.

Pham PC, Pham PM, Pham SV, Miller JM, Pham PTT. Hypomagnesemia in patients with type 2diabetes. Clin J Am Soc Nephrol. 2007;2(2):366-73.

Simmons D, Joshi S, Shaw J. Hypomagnesaemia is associated with diabetes: not pre-diabetes, obesity or the metabolic syndrome. Diabetes Res Clin Pract. 2010;87:261-6.

Gommers LM, Hoenderop JG, Bindels RJ, de Baaij JH. Hypomagnesemia in type 2 diabetes: a vicious circle? Diabetes. 2016;65(1):3-13.

World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO/IDF consultation.

Haider NY, Ziyab AH. Prevalence of prediabetes and its association with obesity among college students in Kuwait: a cross-sectional study. Diabetes Res Clin Pract. 2016;119:71-4.

Koller KR, Metzger JS, Jolly SE, Umans JG, Hopkins SE, Kaufmann C, et al. Cardiometabolic correlates of low type 2 diabetes incidence in western Alaska Native people. Diabetes Res Clin Pract. 2015;108(3):423-31.

Færch K, Witte DR, Tabák AG, Perreault L, Herder C, Brunner EJ, et al. Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study. Lancet Diabetes Endocrinol. 2013;1(1):43-51.

Ligthart S, Herpt TT, Leening MJ, Kavousi M, Hofman A, Stricker BH, et al. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study. Lancet Diabetes Endocrinol. 2016;4(1):44-51.

Pilchova I, Klacanova K, Tatarkova Z, Kaplan P, Racay P. The involvement of Mg2+in regulation of cellular and mitochondrial functions. Oxid Med Cell Longev. 2017;1–8.

Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium: an update on physiological, clinical and analytical aspects. Clinica chimica acta. 2000;294(1-2):1-26.

Lau A, Chan L. Electrolytes, other minerals and trace elements. Basic skills in interpreting laboratory data. 4th edition. American society of Health System Pharmacists. 2009;119-49.

Yajnik CS, Smith RF, Hockaday TD, Ward NI. Fasting plasma magnesium concentrations and glucose disposal in diabetes. Br Med J. 1984;288(6423):1032-4.

Rao PP, Shariff MG. Serum magnesium levels in type 2 diabetic patients with microalbuminuria and normoalbuminuria. Int J Scientific Study. 2015;3(4):11-5.

American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes 2019. Diabetes Care. 2019;42(1):13-28.

Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. The Lancet. 2009;373(9682):2215-21.

Saydah SH, Loria CM, Eberhardt MS, Brancati FL. Subclinical states of glucose intolerance and risk of death in the US. Diabetes care. 2001;24(3):447-53.

Levine C, Coburn JW. Magnesium, the mimic/antagonist of calcium. N Engl J Med. 1984;19:1253-57.

Graham LA, Caesar JJ, Buegen AS. Gastrointestinal absorption and excretion of Mg2+ in man. Metabolism. 1960;9:646-59.

Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L. et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Molecular aspects of medicine. 2003;24(1-3):39-52.

Sumathi K, Chandrika AM. Role of magnesium in prediabetes. Scholars Academic J Pharm. 2015;5(1):12-3.

Babikr WG, Shalayel MHF, Abdelraheem AH, Elhussein A. Impact of body Mass index on hypomagnesemia and hypoocalcemia in Type 2 Diabetic patients. Biomed Pharmacol J. 2016;9(3):933-40.

Nemer R, Wehbe T, Jaoude AE. Serum magnesium association with insulin resistance, pre-diabetes and type 2 diabetes. J Clin Endocrinol Diab. 2018;110:63-9.

Franssens BT, Graaf Y, Kappelle LJ, Westerink J, Borst GJ, Cramer MJ, et al. Body weight, metabolic dysfunction, and risk of type 2 diabetes in patients at high risk for cardiovascular events or with manifest cardiovascular disease: a cohort study. Diabetes Care. 2015;38(10):1945-51.

Hruby A, Meigs JB, O’Donnell CJ, Jacques PF, McKeown NM. Higher magnesium intake reduces risk of impaired glucose and insulin metabolism and progression from prediabetes to diabetes in middle-aged americans. Diabetes Care. 2014;37(2):419-27.

Song Y, Manson JE, Buring JE, Liu S. Dietary magnesium intake in relation to plasma insulin levels and risk of type 2 diabetes in women. Diabetes care. 2004;27(1):59-65.




How to Cite

Koshy, A., & M., R. (2021). Study of serum magnesium levels in pre-diabetics and its correlation to body mass index. International Journal of Research in Medical Sciences, 9(4), 1143–1148.



Original Research Articles